“Bridging the Gap, Empowering Patients: A Collaborative Approach to Rare Disease Research” highlights the significance of adopting a collaborative, patient-centered approach in rare disease research. Led by the Innovation and Value Initiative and Alexion, AstraZeneca Rare Disease, the conversation underscores the importance of transforming the future of rare disease care through collective efforts and patient-centric strategies.
